Get the Stockscreener App
47.32
1.63%
0.89
Tempus Ai Inc stock is traded at $47.32, with a volume of 967.71K.
It is up +1.63% in the last 24 hours and down -5.37% over the past month.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
See More
Previous Close:
$46.43
Open:
$47.36
24h Volume:
967.71K
Relative Volume:
0.17
Market Cap:
$8.47B
Revenue:
$1.36B
Net Income/Loss:
$-302.91M
P/E Ratio:
-27.54
EPS:
-1.7182
Net Cash Flow:
$-219.93M
1W Performance:
-10.63%
1M Performance:
-5.37%
6M Performance:
-38.75%
1Y Performance:
-23.98%
1-Day Range:
$46.18
$47.50
1-Week Range:
$45.84
$53.97
52-Week Range:
$41.73
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Name
Tempus Ai Inc
Sector
Industry
Phone
800-976-5448
Address
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
47.19 | 8.34B | 1.36B | -302.91M | -219.93M | -1.7182 |
VEEV
Veeva Systems Inc
|
170.96 | 28.17B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
59.08 | 11.32B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
88.84 | 7.41B | 1.31B | 215.20M | 408.32M | 2.4627 |
HNGE
Hinge Health Inc
|
64.22 | 4.92B | 646.34M | -512.40M | 202.76M | -6.6871 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-26 | Initiated | Jefferies | Underperform |
| Apr-13-26 | Upgrade | TD Cowen | Hold → Buy |
| Feb-19-26 | Initiated | Mizuho | Outperform |
| Feb-17-26 | Initiated | Robert W. Baird | Outperform |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Oct-21-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Sep-02-25 | Initiated | H.C. Wainwright | Buy |
| Apr-21-25 | Initiated | BTIG Research | Buy |
| Feb-25-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Feb-05-25 | Resumed | TD Cowen | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Dec-09-24 | Initiated | Guggenheim | Buy |
| Nov-11-24 | Downgrade | Stifel | Buy → Hold |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-24 | Initiated | Piper Sandler | Neutral |
| Jul-09-24 | Initiated | BofA Securities | Buy |
| Jul-09-24 | Initiated | JP Morgan | Overweight |
| Jul-09-24 | Initiated | Longbow | Buy |
| Jul-09-24 | Initiated | Loop Capital | Buy |
| Jul-09-24 | Initiated | Morgan Stanley | Overweight |
| Jul-09-24 | Initiated | Needham | Buy |
| Jul-09-24 | Initiated | Stifel | Buy |
| Jul-09-24 | Initiated | TD Cowen | Buy |
| Jul-09-24 | Initiated | William Blair | Outperform |
View All
Tempus Ai Inc Stock (TEM) Latest News
Norges Bank Purchases New Position in Tempus AI, Inc. $TEM - MarketBeat
Contrarius Group Holdings Ltd Makes New Investment in Tempus AI, Inc. $TEM - MarketBeat
Tempus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference - BioSpace
Tempus AI to present at Goldman Sachs healthcare conference - scanx.trade
A Quick Look at Today's Ratings for Tempus AI(TEM.US), With a Forecast Between $60 to $80 - Moomoo
Geode Capital Management LLC Boosts Holdings in Tempus AI, Inc. $TEM - MarketBeat
Tempus AI (NASDAQ:TEM) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Quanterix partners with Tempus AI on Alzheimer’s blood test - Investing.com
Tempus AI, Inc. Class A Common Stock (TEM) Live Share Price, Invest From India - INDmoney
Assessing Tempus AI (TEM) Valuation After Recent Share Price Rebound And Underpriced Growth Narrative - Yahoo Finance
TD Cowen raises Tempus AI stock price target on genomics strength - Investing.com
ARK's Stock Pick: $LLY & $TEM Hold Strong as AI Growth Stocks Plunge — Defensive Biotech Shines - Moomoo
TEM Technical Analysis & Stock Price Forecast - Intellectia AI
AI that predicts clinical outcomes? Tempus AI in focus after ASCO data reveal - MSN
Tempus (TEM) Gets Double-Digit Boost from New Partnerships - Insider Monkey
Tempus AI (NASDAQ:TEM) Trading Up 9.3%Time to Buy? - MarketBeat
Stock Market Today: Nasdaq 100 Slips As Broadcom Plunges, Bitcoin Hits 4-Month Lows - Benzinga
Tempus AI Stock Pops As FDA Win Fuels Growth Story - StocksToTrade
Why Tempus AI Stock Is Surging On Thursday?Tempus AI (NASDAQ:TEM) - Benzinga
Tempus AI falls on wider loss despite revenue beat By Investing.com - Investing.com Australia
Tempus AI (TEM) Jumps As FDA Win Fuels Bullish Momentum - timothysykes.com
Why Is Tempus (TEM) Down 11.2% Since Last Earnings Report? - Yahoo Finance
$Tempus AI (TEM.US)$ thanks for the ride [Drool] - Moomoo
TEM News | TEMPUS AI INC-CL A (NASDAQ:TEM) - ChartMill
Tempus AI launches digital pathology open-source consortium - Investing.com UK
Tempus AI (TEM) director Epstein sells 250 shares in pre-planned trade - Stock Titan
Tempus AI Stock (TEM) Opinions on Analyst Coverage Initiation - Quiver Quantitative
Tempus AI launches digital pathology open-source consortium By Investing.com - Investing.com Nigeria
Tempus AI Launches Open-Source Digital Pathology Consortium With Yale New Haven Health - geneonline.com
Tempus Launches Open-Source Digital Pathology Consortium, Names Yale New Haven Health and Leading Cancer Center as Founding Members - Yahoo Finance
Canaccord Genuity Sticks to Their Buy Rating for Tempus AI, Inc. Class A (TEM) - The Globe and Mail
$Tempus AI (TEM.US)$ someday… you will be wonderful again… - Moomoo
Tempus AI (NASDAQ:TEM) Now Covered by Analysts at Wolfe Research - MarketBeat
Canaccord reiterates Tempus AI stock rating citing growth potential By Investing.com - Investing.com South Africa
Canaccord reiterates Tempus AI stock rating citing growth potential - Investing.com
Tempus AI, Inc. $TEM Shares Bought by Lingotto Investment Management LLP - MarketBeat
H.C. Wainwright Maintains Buy Rating on Tempus AI (TEM) Following Strong Revenue Growth - Insider Monkey
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Tempus AI, Inc. Class A (TEM) and Incyte (INCY) - The Globe and Mail
AXQ Capital LP Buys Shares of 26,002 Tempus AI, Inc. $TEM - MarketBeat
Tempus AI stock gains following the ALERT trial result announcement - MSN
Analysts Have Conflicting Sentiments on These Healthcare Companies: Krystal Biotech (KRYS), AbbVie (ABBV) and Tempus AI, Inc. Class A (TEM) - The Globe and Mail
Wolfe Research initiates Tempus AI stock coverage with Peerperform By Investing.com - Investing.com South Africa
Wolfe Research initiates Tempus AI stock coverage with Peerperform - Investing.com UK
Tempus AI (TEM) Launches Next-Gen Sequencing Test for Oncology - GuruFocus
Stifel Maintains Tempus AI(TEM.US) With Hold Rating, Maintains Target Price $60 - Moomoo
Guggenheim Maintains Tempus AI(TEM.US) With Buy Rating, Maintains Target Price $60 - Moomoo
Tempus xH test finds 40% more genomic findings than standard care - Stock Titan
Needham Maintains Tempus AI(TEM.US) With Buy Rating, Maintains Target Price $75 - Moomoo
Tempus AI (NASDAQ:TEM) Receives "Buy" Rating from Needham & Company LLC - MarketBeat
Tempus AI: Buy Rating Reiterated as Analyst Maintains $75 Price Target on Durable Growth and Improving Financial Profile - TipRanks
William Blair Maintains Tempus AI(TEM.US) With Hold Rating - Moomoo
Tempus Ai Inc Stock (TEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tempus Ai Inc Stock (TEM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| LEFKOFSKY ERIC P | CEO and Chairman |
May 27 '26 |
Sale |
46.70 |
166,250 |
7,763,312 |
8,808,533 |
0.23%
2.95%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):